Why Johnson & Johnson Stock Was Climbing Today
Shares of Johnson & Johnson (NYSE: JNJ) were moving higher today after the company got some favorable legal news.
The healthcare giant reached a settlement worth $8.9 billion over allegations that talc in its baby powder and other products caused ovarian cancer and mesothelioma in tens of thousands of victims.
While that might not sound like good news, the settlement had long been anticipated, and it removes a downside risk that had been nagging the company for years.
Source Fool.com
